FA
MEDP icon

FDx Advisors’s Medpace MEDP Stock Holding History

FDx Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,436
Closed -$580K – 290
2024
Q1 		$580K Sell
1,436
-17
-1% -$5.98K 0.09% 190
2023
Q4 		$445K Sell
1,453
-170
-10% -$45.9K 0.03% 417
2023
Q3 		$393K Sell
1,623
-304
-16% -$77.8K 0.03% 410
2023
Q2 		$463K Buy
+1,927
New +$400K 0.03% 469
2022
Q3 		– Sell
-2,045
Closed -$306K – 783
2022
Q2 		$306K Buy
+2,045
New +$296K 0.01% 626
2022
Q1 		– Sell
-2,557
Closed -$557K – 881
2021
Q4 		$557K Buy
2,557
+1,066
+71% +$223K 0.02% 502
2021
Q3 		$282K Buy
1,491
+236
+19% +$43K 0.01% 686
2021
Q2 		$222K Buy
+1,255
New +$217K 0.01% 756

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

FDx Advisors's MEDP Position: Q2 2024 in Review

FDx Advisors sold out of Medpace (MEDP) in Q2 2024, closing a stake of 1,436 shares — an estimated $580K sold.

FDx Advisors first reported a position in MEDP in Q2 2021 and held it in 8 quarters. The position peaked at $580K in Q1 2024. 623 funds tracked by Wall St. Rank hold MEDP as of Q2 2024.

  • FDx Advisors reported no remaining Medpace position as of Q2 2024 after selling out during the quarter.
  • FDx Advisors sold 1,436 Medpace shares in Q2 2024, an estimated $580K.
  • FDx Advisors first reported a position in Medpace in Q2 2021 and held it in 8 quarters.
  • FDx Advisors's Medpace position peaked at $580K in Q1 2024.
  • 623 funds tracked by Wall St. Rank held Medpace as of Q2 2024.

Based on FDx Advisors's 13F filing for Q2 2024, filed 2 Aug 2024.